Transcend Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.67M | Sell |
57,576
-43,496
| -43% | -$2.01M | 0.21% | 114 |
|
|
2025
Q1 | $6.16M | Sell |
101,072
-94,725
| -48% | -$5.78M | 0.44% | 46 |
|
|
2024
Q4 | $11.1M | Sell |
195,797
-3,965
| -2% | -$224K | 0.8% | 24 |
|
|
2024
Q3 | $10.3M | Sell |
199,762
-1,318
| -0.7% | -$68.2K | 0.69% | 30 |
|
|
2024
Q2 | $8.35M | Buy |
201,080
+4,354
| +2% | +$181K | 0.61% | 34 |
|
|
2024
Q1 | $10.7M | Buy |
196,726
+35,159
| +22% | +$1.91M | 0.86% | 22 |
|
|
2023
Q4 | $8.29M | Buy |
161,567
+37,853
| +31% | +$1.94M | 0.74% | 26 |
|
|
2023
Q3 | $7.18M | Sell |
123,714
-1,980
| -2% | -$115K | 0.7% | 28 |
|
|
2023
Q2 | $8.04M | Sell |
125,694
-3,431
| -3% | -$219K | 0.77% | 23 |
|
|
2023
Q1 | $8.95M | Buy |
129,125
+398
| +0.3% | +$27.6K | 0.93% | 18 |
|
|
2022
Q4 | $9.26M | Sell |
128,727
-3,527
| -3% | -$254K | 1.01% | 19 |
|
|
2022
Q3 | $9.4M | Buy |
132,254
+2,893
| +2% | +$206K | 1.04% | 14 |
|
|
2022
Q2 | $9.96M | Sell |
129,361
-261
| -0.2% | -$20.1K | 1.04% | 14 |
|
|
2022
Q1 | $9.47M | Buy |
129,622
+1,349
| +1% | +$98.5K | 0.85% | 19 |
|
|
2021
Q4 | $8M | Sell |
128,273
-1,034
| -0.8% | -$64.5K | 0.71% | 24 |
|
|
2021
Q3 | $7.53M | Sell |
129,307
-32,387
| -20% | -$1.89M | 0.68% | 26 |
|
|
2021
Q2 | $10.8M | Buy |
161,694
+910
| +0.6% | +$60.8K | 1.55% | 8 |
|
|
2021
Q1 | $10.1M | Sell |
160,784
-3,213
| -2% | -$203K | 1.22% | 11 |
|
|
2020
Q4 | $10.2M | Sell |
163,997
-26,843
| -14% | -$1.67M | 1.34% | 10 |
|
|
2020
Q3 | $11.5M | Sell |
190,840
-2,869
| -1% | -$173K | 2.09% | 6 |
|
|
2020
Q2 | $11.4M | Sell |
193,709
-8,237
| -4% | -$484K | 3.71% | 4 |
|
|
2020
Q1 | $11.3M | Sell |
201,946
-1,265
| -0.6% | -$70.5K | 3.37% | 3 |
|
|
2019
Q4 | $13M | Buy |
+203,211
| New | +$13M | 3.51% | 3 |
|